Skip to main content

Table 2 Multivariate logistic regression analysis of covariates for the risk of 28-day mortality in ALI patients

From: Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome – a retrospective propensity matched cohort study

 

OR (95% CI)

Pvalue*

Age

1.02 (1.00/1.03)

0.002

Male

1.39 (0.92/1.86)

0.13

APACHE II score

1.09 (1.06/1.12)

< 0.001

Medical

1.94 (1.34/2.81)

< 0.001

Surgery Elective

0.40 (0.25/0.65)

< 0.001

Surgery Emergency

0.91 (0.57/1.45)

0.68

Medical conditions

Multiple Trauma

0.51 (0.22/1.15)

0.11

Sepsis

1.27 (0.84/1.90)

0.25

Diabetes

1.83 (1.18/2.83)

0.006

Liver Failure

3.82 (1.48/9.82)

0.006

Hematological malignancy

1.77 (0.89/3.49)

0.10

Aspiration

1.35 (0.63/2.91)

0.44

Pancreatitis

0.67 (0.19/2.38)

0.54

Pneumonia

1.14 (0.75/1.71)

0.55

COPD

1.26 (0.76/2.07)

0.37

Auto immune disease

1.95 (1.07/3.56)

0.03

Previous Myocardial infarction

1.25 (0.83/1.89)

0.29

Immune Compromised

1.69 (1.00/2.83)

0.05

Massive Transfusion

0.68 (0.40/1.16)

0.16

Life support measures

Respiratory failure at admission

1.00 (0.98/1.02)

0.99

Cardiovascular failure (inotropic at admission)

1.00 (0.98/1.02)

0.84

Co interventions

Activated Protein C

1.40 (0.59/3.29)

0.45

Stress dose steroids

1.89 (1.34/2.64)

< 0.001

Protective mechanical ventilation (<8 ml/kg)

0.63 (0.45/0.89)

0.008

Restrictive fluid strategy (net fluid balance first 7 days ≤ 0 ml)

0.33 (0.22/0.49)

< 0.001

  1. * Potentially confounder (p value ≤ 0.10). COPD = chronic obstructive pulmonary disease, OR = odds ratio, CI = 95% confidence limit.